InvestSMART

Archer Materials Limited (ASX: AXE) - Announcements

Current share price for AXE : $0.225 0.01 (4.65%)+

ASX company news and announcements for Archer Materials Limited (AXE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Archer Materials Limited (AXE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Archer Materials Limited (AXE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Archer Materials Limited (AXE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$63 Proof of concept devices to improve 12CQ chip spin detection 3 Sep 2024 9:14AM $0.240 $0.225 fallen by 6.25%
$63 2024 Corporate Governance Statement and Appendix 4G 28 Aug 2024 1:21PM $0.275 $0.225 fallen by 18.18%
$63 Appendix 4E and 2024 Annual Report 28 Aug 2024 1:17PM $0.275 $0.225 fallen by 18.18%
$63 Biochip experiments begin to develop kidney disease testing 27 Aug 2024 8:41AM $0.255 $0.225 fallen by 11.76%
$63 New Integrated biochip gFET to bolster functionality 16 Aug 2024 9:21AM $0.235 $0.225 fallen by 4.26%
$63 Quarterly Activity Report & Appendix 4C 26 Jul 2024 8:55AM $0.285 $0.225 fallen by 21.05%
$63 New Biochip gFET test procedure and process developed 23 Jul 2024 8:33AM $0.300 $0.225 fallen by 25%
$63 Quantum technology project update 18 Jul 2024 9:16AM $0.280 $0.225 fallen by 19.64%
$63 Management restructure 15 Jul 2024 8:52AM $0.360 $0.225 fallen by 37.50%
$63 Departure of CEO 12 Jul 2024 7:09PM $0.360 $0.225 fallen by 37.50%
$63 Notification of cessation of securities - AXE 28 Jun 2024 4:41PM $0.335 $0.225 fallen by 32.84%
$63 Archer Biochip gFET design fabricated on a six-inch wafer 17 Jun 2024 11:41AM $0.365 $0.225 fallen by 38.36%
$63 Notification of cessation of securities - AXE 9 May 2024 2:45PM $0.455 $0.225 fallen by 50.55%
$63 Quarterly Activity Report & Appendix 4C 29 Apr 2024 10:01AM $0.505 $0.225 fallen by 55.45%
$63 Change in substantial holding for CMX 9 Apr 2024 4:55PM $0.505 $0.225 fallen by 55.45%
$63 Sharecafe Investor Presentation 5 Apr 2024 12:30PM $0.520 $0.225 fallen by 56.73%
$63 Change of Director's Interest Notice 2 Apr 2024 6:07PM $0.550 $0.225 fallen by 59.09%
$63 Notification of cessation of securities - AXE 2 Apr 2024 5:59PM $0.550 $0.225 fallen by 59.09%
$63 Archer and EPFL develop a single chip pulsed ESR microsystem 25 Mar 2024 9:12AM $0.470 $0.225 fallen by 52.13%
$63 Archer miniaturises Biochip gFET chip design 11 Mar 2024 10:06AM $0.390 $0.225 fallen by 42.31%
$63 Appendix 4D and Half Year Financial Report 16 Feb 2024 1:09PM $0.345 $0.225 fallen by 34.78%
$63 Quarterly Activity Report & Appendix 4C 24 Jan 2024 11:53AM $0.335 $0.225 fallen by 32.84%
$63 Notification of cessation of securities - AXE 16 Jan 2024 4:25PM $0.350 $0.225 fallen by 35.71%
$63 New Biochip gFET design sent to foundry partner in Spain 11 Dec 2023 11:57AM $0.375 $0.225 fallen by 40%
$63 Results of 2023 Annual General Meeting 29 Nov 2023 4:01PM $0.395 $0.225 fallen by 43.04%

101 - 125 of 917 results

Page 5 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.